Quark Scuttles IPO Plans for the Second Time
September 29, 2011
Quark Scuttles IPO Plans for the Second Time
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Still Eyeing IPO, Quark Says Cost Expectations for Rx Pipeline Exceed $54M
January 27, 2011 / Gene Silencing News - Quark SEC Filing Provides New Details on Company Pipeline, Financials
October 7, 2010 / Gene Silencing News - Quark to Run Phase IIa Trial of RNAi Drug in Glaucoma
May 3, 2012 / Gene Silencing News - Isis Exec Sees Antisense as Third Major Drug Platform, Says More Work to Be Done
April 19, 2012 / Gene Silencing News - Quark Still Sees IPO as a Possibility as Phase II Trials Near Completion
February 9, 2012 / Gene Silencing News